# RYANODEX dantrolene sodium

NDC: 42367-540
Generic name: dantrolene sodium
Labeler / Manufacturer: Eagle Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20140723

FDA application: NDA205579

## Active ingredients

- DANTROLENE SODIUM: 250 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42367-540"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42367-540
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f7b3ac0-604d-4c78-b545-5e0f8ea3d698